# Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients

> **NCT01395823** · PHASE4 · COMPLETED · sponsor: **Dialysis Clinic, Inc.** · enrollment: 470 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DIETARY_SUPPLEMENT:** ergocalciferol supplementation
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT01395823
- **Lead sponsor:** Dialysis Clinic, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2014-04
- **Final completion:** 2015-06
- **Target enrollment:** 470 (ACTUAL)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395823, "Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01395823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*